<p>Pediatrix Medical Group, Inc. (NYSE:MD - 獲取免費報告) 的股價在週四的交易中下跌了 3.5%，原因是內部人士出售股票。該公司股價最低跌至 22.14 美元，最後交易價格為 21.7650 美元。在交易中，共成交 42,312 股，較平均交易量 803,766 股下降了 95%。該股票此前收盤價為 22.56 美元。</p>
<ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
<p>具體來説，首席執行官馬克·S·奧爾丹在 12 月 15 日（星期一）出售了 23,000 股公司的股票。股票以平均價格 22.41 美元出售，總交易額為 515,430.00 美元。交易後，首席執行官持有 302,805 股公司的股票，價值約為 6,785,860.05 美元。這筆交易代表了他們持股比例的 7.06% 的減少。該出售在與證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。</p>
<h2>分析師評級升級與降級</h2>
<p>幾家券商對 MD 發表了評論。瑞銀集團在 11 月 5 日的研究報告中將 Pediatrix Medical Group 的目標股價從 16.50 美元上調至 23.00 美元，並給予該公司 “中性” 評級。Weiss Ratings 在週一的研究報告中重申了對 Pediatrix Medical Group 的 “持有（c+）” 評級。華爾街 Zen 在 10 月 4 日的報告中將 Pediatrix Medical Group 的評級從 “買入” 上調至 “強力買入”。Truist Financial 在 11 月 10 日的研究報告中將 Pediatrix Medical Group 的目標股價從 17.00 美元上調至 24.00 美元，並給予該公司 “持有” 評級。最後，Zacks Research 在 11 月 21 日的報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。一位分析師給予該股票 “強力買入” 評級，一位給予 “買入” 評級，四位給予 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 21.00 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
<p><strong>獲取我們最新的 MD 股票報告</strong></p>
<h2>Pediatrix Medical Group 股票表現</h2>
<p>該公司的市值為 18.5 億美元，市盈率為 11.48，貝塔值為 0.77。該公司的速動比率為 1.83，流動比率為 1.83，債務股本比率為 0.65。該股票的 50 日移動平均價格為 20.73 美元，200 日移動平均價格為 16.92 美元。</p>
<ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
<p>Pediatrix Medical Group (NYSE:MD - 獲取免費報告) 最近在 11 月 3 日（星期一）發佈了其財報。該公司報告本季度每股收益為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。該業務本季度的收入為 4.9288 億美元，而分析師預期為 4.7645 億美元。Pediatrix Medical Group 的淨利潤率為 8.44%，股本回報率為 20.45%。該業務的季度收入同比下降了 3.6%。在去年同期，該業務的每股收益為 0.44 美元。分析師預計 Pediatrix Medical Group, Inc.在當前財政年度將發佈 1.38 美元的每股收益。</p>
<h2>機構投資者對 Pediatrix Medical Group 的看法</h2>
<p>幾家對沖基金和其他機構投資者最近增加或減少了對該公司的持股。Smartleaf Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 10.6%。Smartleaf Asset Management LLC 現在擁有 6,250 股該公司的股票，價值 101,000 美元，此前在上個季度又購買了 601 股。PNC 金融服務集團在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 4.5%。PNC 金融服務集團現在擁有 14,525 股該公司的股票，價值 243,000 美元，此前在此期間又購買了 631 股。Gotham Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 0.6%。Gotham Asset Management LLC 現在擁有 116,093 股該公司的股票，價值 1,945,000 美元，此前在上個季度又購買了 724 股。AlphaQuest LLC 在第一季度將其在 Pediatrix Medical Group 的持股比例提高了 16.0%。AlphaQuest LLC 現在擁有 5,877 股該公司的股票，價值 85,000 美元，此前在上個季度又購買了 811 股。最後，Amalgamated Bank 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 3.5%。Amalgamated Bank 現在擁有 24,891 股該公司的股票，價值 417,000 美元，此前在上個季度又購買了 831 股。目前 97.71% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於 Pediatrix Medical Group</h2>
<p>(獲取免費報告)</p>
<p>Pediatrix Medical Group, Inc.及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，例如通過新生兒醫生專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內對早產或有併發症的嬰兒進行臨牀護理。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票比 Pediatrix Medical Group 更好</li>
<li>你應該投資於便士股票嗎？</li>
<li>2026 年可能會反彈的三隻新年決心股票</li>
<li>工業產品股票投資</li>
<li>大麻股票反轉：幻想還是機會？</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>降息使這三隻收入 ETF 比以往更具吸引力</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Pediatrix Medical Group 嗎？</h2>
<p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Pediatrix Medical Group 並不在名單上。</p>
<p>雖然 Pediatrix Medical Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Pediatrix Medical Group 的股價在首席執行官 Mark S. Ordan 出售 23,000 股後下跌了 3.5%。該股最低交易價為 22.14 美元，交易量顯著下降。分析師的評級不一，有些將該股評級上調至 “強烈買入”。公司報告的收益超出預期，淨利潤率為 8.44%，股本回報率為 20.45%。機構投資者持有 97.71% 的股份</p>

<p>Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s stock price traded down 3.5% during trading on Thursday following insider selling activity. The company traded as low as $22.14 and last traded at $21.7650. 42,312 shares traded hands during trading, a decline of 95% from the average session volume of 803,766 shares. The stock had previously closed at $22.56.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. (NYSE:MD - 獲取免費報告) 的股價在週四的交易中下跌了 3.5%，原因是內部人士出售股票。該公司股價最低跌至 22.14 美元，最後交易價格為 21.7650 美元。在交易中，共成交 42,312 股，較平均交易量 803,766 股下降了 95%。該股票此前收盤價為 22.56 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撐——現在正在獲得動能</li>
</ul>
</div><p>Specifically, CEO Mark S. Ordan sold 23,000 shares of the firm's stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $22.41, for a total transaction of $515,430.00. Following the transaction, the chief executive officer owned 302,805 shares of the company's stock, valued at approximately $6,785,860.05. This trade represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website.</p>
<div class="lb-trans"><p>具體來説，首席執行官馬克·S·奧爾丹在 12 月 15 日（星期一）出售了 23,000 股公司的股票。股票以平均價格 22.41 美元出售，總交易額為 515,430.00 美元。交易後，首席執行官持有 302,805 股公司的股票，價值約為 6,785,860.05 美元。這筆交易代表了他們持股比例的 7.06% 的減少。該出售在與證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站獲取。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級升級與降級</h2>
</div><p>Several brokerages have commented on MD. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, November 5th. Weiss Ratings reiterated a &#34;hold (c+)&#34; rating on shares of Pediatrix Medical Group in a research report on Monday. Wall Street Zen raised Pediatrix Medical Group from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, October 4th. Truist Financial lifted their price target on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a &#34;hold&#34; rating in a research report on Monday, November 10th. Finally, Zacks Research upgraded Pediatrix Medical Group from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 21st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $21.00.</p>
<div class="lb-trans"><p>幾家券商對 MD 發表了評論。瑞銀集團在 11 月 5 日的研究報告中將 Pediatrix Medical Group 的目標股價從 16.50 美元上調至 23.00 美元，並給予該公司 “中性” 評級。Weiss Ratings 在週一的研究報告中重申了對 Pediatrix Medical Group 的 “持有（c+）” 評級。華爾街 Zen 在 10 月 4 日的報告中將 Pediatrix Medical Group 的評級從 “買入” 上調至 “強力買入”。Truist Financial 在 11 月 10 日的研究報告中將 Pediatrix Medical Group 的目標股價從 17.00 美元上調至 24.00 美元，並給予該公司 “持有” 評級。最後，Zacks Research 在 11 月 21 日的報告中將 Pediatrix Medical Group 的評級從 “持有” 上調至 “強力買入”。一位分析師給予該股票 “強力買入” 評級，一位給予 “買入” 評級，四位給予 “持有” 評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 21.00 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/18 - 08/22</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on MD</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 MD 股票報告</strong></p>
</div><h2>Pediatrix Medical Group Stock Performance</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票表現</h2>
</div><p>The firm has a market cap of $1.85 billion, a price-to-earnings ratio of 11.48 and a beta of 0.77. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average price of $20.73 and a 200-day moving average price of $16.92.</p>
<div class="lb-trans"><p>該公司的市值為 18.5 億美元，市盈率為 11.48，貝塔值為 0.77。該公司的速動比率為 1.83，流動比率為 1.83，債務股本比率為 0.65。該股票的 50 日移動平均價格為 20.73 美元，200 日移動平均價格為 16.92 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投資者的機會變得更健康</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.21. The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The business's quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.44 EPS. On average, analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group (NYSE:MD - 獲取免費報告) 最近在 11 月 3 日（星期一）發佈了其財報。該公司報告本季度每股收益為 0.67 美元，超出市場共識預期的 0.46 美元，超出幅度為 0.21 美元。該業務本季度的收入為 4.9288 億美元，而分析師預期為 4.7645 億美元。Pediatrix Medical Group 的淨利潤率為 8.44%，股本回報率為 20.45%。該業務的季度收入同比下降了 3.6%。在去年同期，該業務的每股收益為 0.44 美元。分析師預計 Pediatrix Medical Group, Inc.在當前財政年度將發佈 1.38 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>機構投資者對 Pediatrix Medical Group 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company's stock valued at $101,000 after buying an additional 601 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of Pediatrix Medical Group by 4.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company's stock worth $243,000 after buying an additional 631 shares during the period. Gotham Asset Management LLC boosted its position in Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company's stock worth $1,945,000 after purchasing an additional 724 shares during the last quarter. AlphaQuest LLC grew its position in shares of Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Finally, Amalgamated Bank grew its stake in Pediatrix Medical Group by 3.5% in the 3rd quarter. Amalgamated Bank now owns 24,891 shares of the company's stock worth $417,000 after acquiring an additional 831 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近增加或減少了對該公司的持股。Smartleaf Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 10.6%。Smartleaf Asset Management LLC 現在擁有 6,250 股該公司的股票，價值 101,000 美元，此前在上個季度又購買了 601 股。PNC 金融服務集團在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 4.5%。PNC 金融服務集團現在擁有 14,525 股該公司的股票，價值 243,000 美元，此前在此期間又購買了 631 股。Gotham Asset Management LLC 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 0.6%。Gotham Asset Management LLC 現在擁有 116,093 股該公司的股票，價值 1,945,000 美元，此前在上個季度又購買了 724 股。AlphaQuest LLC 在第一季度將其在 Pediatrix Medical Group 的持股比例提高了 16.0%。AlphaQuest LLC 現在擁有 5,877 股該公司的股票，價值 85,000 美元，此前在上個季度又購買了 811 股。最後，Amalgamated Bank 在第三季度將其在 Pediatrix Medical Group 的持股比例提高了 3.5%。Amalgamated Bank 現在擁有 24,891 股該公司的股票，價值 417,000 美元，此前在上個季度又購買了 831 股。目前 97.71% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>關於 Pediatrix Medical Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc.及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，例如通過新生兒醫生專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內對早產或有併發症的嬰兒進行臨牀護理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>Should You Invest in Penny Stocks?</li>
<li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li>
<li>Industrial Products Stocks Investing</li>
<li>Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?</li>
<li>Russell 2000 Index, How Investors Use it For Profitable Trading</li>
<li>Rate Cuts Make These 3 Income ETFs More Attractive Than Ever</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Pediatrix Medical Group 更好</li>
<li>你應該投資於便士股票嗎？</li>
<li>2026 年可能會反彈的三隻新年決心股票</li>
<li>工業產品股票投資</li>
<li>大麻股票反轉：幻想還是機會？</li>
<li>羅素 2000 指數，投資者如何利用它進行盈利交易</li>
<li>降息使這三隻收入 ETF 比以往更具吸引力</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Pediatrix Medical Group 嗎？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Pediatrix Medical Group 並不在名單上。</p>
</div><p>While Pediatrix Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Pediatrix Medical Group 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Pediatrix Medical Group（NYSE:MD）在內部人士拋售後股價下跌 3.5%